Article
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.
The Journal of allergy and clinical immunology - 1 Apr 2008
Mrabet-Dahbi Salima, Dalpke Alexander H, Niebuhr Margarete, Frey Markus, Draing Christian, Brand Stephanie, Heeg Klaus, Werfel Thomas, Renz Harald
Abstract excerpt
BACKGROUND: Impaired host defense mechanisms may crucially modulate the pathogenesis of atopic dermatitis (AD). More than 10% of patients with AD are heterozygous for the Toll-like receptor 2 (TLR-2) R753Q single nucleotide polymorphism (SNP) and exhibit severe eczema. OBJECTIVE: To elucidate the functional effect of the TLR-2 mutation and its putative relevance for AD. METHODS: Using the human embryonic kidney...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
